Physician
Smith, Jessica
Smith, Jessica was paid $591K by Medicaid between Aug 2019 and Dec 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoSMITH, JESSICA
HELENA, MT 59601
HELENA, MT 59601
33aNPI1619363629assigned 04/07/2015
33bProvider typePediatrics Physician
28Total paid$591K
24GClaims7,692
24DCodes billed21
24AFirst – last monthAug 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Montana
Rank by total paid#6 of 16
Median peer was paid$371K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 616 | $31K | |
| 2020 | 1,312 | $90K | |
| 2021 | 1,773 | $110K | |
| 2022 | 1,691 | $143K | |
| 2023 | 1,141 | $106K | |
| 2024incomplete | 1,159 | $110K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 2,946 | 2,752 | $294K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 1,340 | 1,263 | $183K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 7.1% | 322 | 315 | $42K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.3% | 501 | 487 | $25K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.2% | 248 | 242 | $25K |
| 99072 | <1% | 1,102 | 1,053 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 154 | 146 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 72 | 61 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 218 | 176 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 16 | 15 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | 13 | $2K |
| 92551 | <1% | 121 | 112 | $1K |
9 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 61 | $991.80 |
| 96127 | <1% | 102 | $572.82 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $421.08 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 15 | $323.84 |
| 85018 | <1% | 27 | $61.62 | |
| 90686 | <1% | 286 | $41.10 | |
| 90656 | 0% | 23 | $0.00 | |
| 99177 | 0% | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.